1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    























































































































    Differentiation of Tumor Progression from Pseudoprogression in Patients with Posttreatment Glioblastoma Using Multiparametric Histogram Analysis | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      

  
      
Differentiation of Tumor Progression from Pseudoprogression in Patients with Posttreatment Glioblastoma Using Multiparametric Histogram Analysis
  
    	
J. Cha, S.T. Kim, H.-J. Kim, B.-j. Kim, Y.K. Kim, J.Y. Lee, P. Jeon, K.H. Kim, D.-s. Kong and D.-H. Nam

  
    	
American Journal of Neuroradiology July 2014,  35 (7) 1309-1317; DOI: https://doi.org/10.3174/ajnr.A3876 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Stupp  R, 
    2. Mason  WP, 
    3. van den Bent  MJ, 
    4. et al
    . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96
    CrossRefPubMedWeb of Science
  2. 2.↵


    1. Caroline  I, 
    2. Rosenthal  MA
    . Imaging modalities in high-grade gliomas: pseudoprogression, recurrence, or necrosis? J Clin Neurosci 2012;19:633–37
    CrossRefPubMed
  3. 3.↵


    1. Yang  I, 
    2. Aghi  MK
    . New advances that enable identification of glioblastoma recurrence. Nat Rev Clin Oncol 2009;6:648–57
    CrossRefPubMedWeb of Science
  4. 4.↵


    1. Brandsma  D, 
    2. Stalpers  L, 
    3. Taal  W, 
    4. et al
    . Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 2008;9:453–61
    CrossRefPubMedWeb of Science
  5. 5.↵


    1. Chaskis  C, 
    2. Neyns  B, 
    3. Michotte  A, 
    4. et al
    . Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations. Surg Neurol 2009;72:423–28
    CrossRefPubMedWeb of Science
  6. 6.↵


    1. Kong  DS, 
    2. Kim  ST, 
    3. Kim  EH, 
    4. et al
    . Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6-methylguanine-DNA methyltransferase promoter methylation status. AJNR Am J Neuroradiol 2011;32:382–87
    Abstract/FREE Full Text
  7. 7.↵


    1. Husby  JA, 
    2. Espeland  A, 
    3. Kalyanpur  A, 
    4. et al
    . Double reading of radiological examinations in Norway. Acta Radiol 2011;52:516–21
    Abstract/FREE Full Text
  8. 8.↵


    1. Baek  HJ, 
    2. Kim  HS, 
    3. Kim  N, 
    4. et al
    . Percent change of perfusion skewness and kurtosis: a potential imaging biomarker for early treatment response in patients with newly diagnosed glioblastomas. Radiology 2012;264:834–43
    CrossRefPubMed
  9. 9.↵


    1. Wen  PY, 
    2. Macdonald  DR, 
    3. Reardon  DA, 
    4. et al
    . Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology Working Group. J Clin Oncol 2010;28:1963–72
    Abstract/FREE Full Text
  10. 10.↵


    1. Asao  C, 
    2. Korogi  Y, 
    3. Kitajima  M, 
    4. et al
    . Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 2005;26:1455–60
    Abstract/FREE Full Text
  11. 11.↵


    1. Hygino da Cruz  LC  Jr., 
    2. Rodriguez  I, 
    3. Domingues  RC, 
    4. et al
    . Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 2011;32:1978–85
    Abstract/FREE Full Text
  12. 12.↵


    1. Mangla  R, 
    2. Singh  G, 
    3. Ziegelitz  D, 
    4. et al
    . Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma. Radiology 2010;256:575–84
    CrossRefPubMedWeb of Science
  13. 13.↵


    1. Kim  HS, 
    2. Kim  JH, 
    3. Kim  SH, 
    4. et al
    . Posttreatment high-grade glioma: usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence. Radiology 2010;256:906–15
    CrossRefPubMedWeb of Science
  14. 14.↵


    1. Hu  LS, 
    2. Eschbacher  JM, 
    3. Heiserman  JE, 
    4. et al
    . Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival. Neuro Oncol 2012;14:919–30
    Abstract/FREE Full Text
  15. 15.↵


    1. Ostergaard  L, 
    2. Weisskoff  RM, 
    3. Chesler  DA, 
    4. et al
    . High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I. Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715–25
    CrossRefPubMedWeb of Science
  16. 16.↵


    1. Boxerman  JL, 
    2. Schmainda  KM, 
    3. Weisskoff  RM
    . Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859–67
    Abstract/FREE Full Text
  17. 17.↵


    1. Boxerman  JL, 
    2. Prah  DE, 
    3. Paulson  ES, 
    4. et al
    . The role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard. AJNR Am J Neuroradiol 2012;33:1081–87
    Abstract/FREE Full Text
  18. 18.↵


    1. Maes  F, 
    2. Collignon  A, 
    3. Vandermeulen  D, 
    4. et al
    . Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging 1997;16:187–98
    CrossRefPubMedWeb of Science
  19. 19.↵


    1. Yoshii  Y
    . Pathological review of late cerebral radionecrosis. Brain Tumor Pathol 2008;25:51–58
    CrossRefPubMedWeb of Science
  20. 20.↵


    1. Tung  GA, 
    2. Evangelista  P, 
    3. Rogg  JM, 
    4. et al
    . Diffusion-weighted MR imaging of rim-enhancing brain masses: is markedly decreased water diffusion specific for brain abscess? AJR Am J Roentgenol 2001;177:709–12
    CrossRefPubMedWeb of Science
  21. 21.↵


    1. Cha  J, 
    2. Kim  ST, 
    3. Kim  HJ, 
    4. et al
    . Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression. Eur Radiol 2013;23:879–86
    CrossRefPubMed
  22. 22.↵


    1. Emblem  KE, 
    2. Nedregaard  B, 
    3. Nome  T, 
    4. et al
    . Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 2008;247:808–17
    CrossRefPubMedWeb of Science
  23. 23.↵


    1. Law  M, 
    2. Young  R, 
    3. Babb  J, 
    4. et al
    . Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 2007;28:761–66
    Abstract/FREE Full Text
  24. 24.↵


    1. Brandes  AA, 
    2. Franceschi  E, 
    3. Tosoni  A, 
    4. et al
    . MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 2008;26:2192–97
    Abstract/FREE Full Text
  25. 25.↵


    1. Taal  W, 
    2. Brandsma  D, 
    3. de Bruin  HG, 
    4. et al
    . Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. Cancer 2008;113:405–10
    CrossRefPubMedWeb of Science
  26. 26.↵


    1. Chamberlain  MC
    . Pseudoprogression in glioblastoma. J Clin Oncol 2008;26:4359, author reply 4359–60
    FREE Full Text
  27. 27.↵


    1. Chamberlain  MC, 
    2. Glantz  MJ, 
    3. Chalmers  L, 
    4. et al
    . Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 2007;82:81–83
    CrossRefPubMed
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Differentiation of Tumor Progression from Pseudoprogression in Patients with Posttreatment Glioblastoma Using Multiparametric Histogram Analysis
  
    	
J. Cha, S.T. Kim, H.-J. Kim, B.-j. Kim, Y.K. Kim, J.Y. Lee, P. Jeon, K.H. Kim, D.-s. Kong, D.-H. Nam

  
    	
American Journal of Neuroradiology Jul 2014, 35 (7) 1309-1317; DOI: 10.3174/ajnr.A3876 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement